These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 24314353)
1. JCL Roundtable: diagnosis of severe familial hypercholesterolemia. Brown WV; Rader DJ; Kane J J Clin Lipidol; 2013; 7(6):540-5. PubMed ID: 24314353 [TBL] [Abstract][Full Text] [Related]
2. Sorting the wheat from the chaff in familial hypercholesterolemia. Hooper AJ; Watts GF Clin Chem; 2015 Jan; 61(1):6-8. PubMed ID: 25391991 [No Abstract] [Full Text] [Related]
3. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients. Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841 [TBL] [Abstract][Full Text] [Related]
5. Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease - A study supported by the Korean Society of Lipidology and Atherosclerosis. Shin DG; Han SM; Kim DI; Rhee MY; Lee BK; Ahn YK; Cho BR; Woo JT; Hur SH; Jeong JO; Jang Y; Lee JH; Lee SH Atherosclerosis; 2015 Nov; 243(1):53-8. PubMed ID: 26343872 [TBL] [Abstract][Full Text] [Related]
6. Effect of the proprotein convertase subtilisin/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia. Stein EA; Honarpour N; Wasserman SM; Xu F; Scott R; Raal FJ Circulation; 2013 Nov; 128(19):2113-20. PubMed ID: 24014831 [TBL] [Abstract][Full Text] [Related]
8. [Familial hypercholesterolemia - do we think enough about this severe disease?]. Pećin I; Sućur N; Reiner Z Lijec Vjesn; 2013; 135(5-6):145-9. PubMed ID: 23898695 [TBL] [Abstract][Full Text] [Related]
9. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study. Saavedra YG; Dufour R; Davignon J; Baass A Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291 [TBL] [Abstract][Full Text] [Related]
10. [Familial hypercholesterolemia in Tunisia]. Jelassi A; Jguirim I; Najah M; Maatouk F; Ben Hamda K; Slimane MN Pathol Biol (Paris); 2009 Jul; 57(5):444-50. PubMed ID: 19041195 [TBL] [Abstract][Full Text] [Related]
11. A novel type of familial hypercholesterolemia: double heterozygous mutations in LDL receptor and LDL receptor adaptor protein 1 gene. Tada H; Kawashiri MA; Ohtani R; Noguchi T; Nakanishi C; Konno T; Hayashi K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M Atherosclerosis; 2011 Dec; 219(2):663-6. PubMed ID: 21872251 [TBL] [Abstract][Full Text] [Related]
12. [Molecular basis of familial hypercholesterolemia-like phenotype heterogeneity]. Wang LY; Lin J; Liu S; Chen BS Yi Chuan Xue Bao; 2005 Jul; 32(7):770-7. PubMed ID: 16078748 [TBL] [Abstract][Full Text] [Related]
14. No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes. Damgaard D; Jensen JM; Larsen ML; Soerensen VR; Jensen HK; Gregersen N; Jensen LG; Faergeman O Atherosclerosis; 2004 Dec; 177(2):415-22. PubMed ID: 15530918 [TBL] [Abstract][Full Text] [Related]
15. Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries. Futema M; Shah S; Cooper JA; Li K; Whittall RA; Sharifi M; Goldberg O; Drogari E; Mollaki V; Wiegman A; Defesche J; D'Agostino MN; D'Angelo A; Rubba P; Fortunato G; Waluś-Miarka M; Hegele RA; Aderayo Bamimore M; Durst R; Leitersdorf E; Mulder MT; Roeters van Lennep JE; Sijbrands EJ; Whittaker JC; Talmud PJ; Humphries SE Clin Chem; 2015 Jan; 61(1):231-8. PubMed ID: 25414277 [TBL] [Abstract][Full Text] [Related]
16. The contribution of PCSK9 levels to the phenotypic severity of familial hypercholesterolemia is independent of LDL receptor genotype. Drouin-Chartier JP; Tremblay AJ; Hogue JC; Ooi TC; Lamarche B; Couture P Metabolism; 2015 Nov; 64(11):1541-7. PubMed ID: 26371983 [TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of familial hypercholesterolaemia in Western Australia. Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975 [TBL] [Abstract][Full Text] [Related]
19. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol. Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564 [TBL] [Abstract][Full Text] [Related]
20. The genetic spectrum of familial hypercholesterolemia in south-eastern Poland. Sharifi M; Walus-Miarka M; Idzior-Waluś B; Malecki MT; Sanak M; Whittall R; Li KW; Futema M; Humphries SE Metabolism; 2016 Mar; 65(3):48-53. PubMed ID: 26892515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]